Hepatitis B antiviral resistance and vaccine escape: two sides of the same coin.
Victorian Infectious Diseases Service, Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia. josepht@unimelb.edu.au
Joseph
J
Torresi
D000937:Antigen-Antibody Reactions; D000998:Antiviral Agents / Q000494:pharmacology; D024921:Drug Resistance, Multiple, Viral / Q000235:genetics*; D015971:Gene Expression Regulation, Enzymologic; D015967:Gene Expression Regulation, Viral / Q000187:drug effects; D015684:Gene Products, pol / Q000235:genetics*; D006510:Hepatitis B Antibodies / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000235:genetics / Q000276:immunology; D017325:Hepatitis B Vaccines / Q000276:immunology*; D006515:Hepatitis B virus / Q000187:drug effects / Q000201:enzymology / Q000235:genetics* / Q000276:immunology; D006801:Humans; D016056:Immunodominant Epitopes / Q000235:genetics; D009154:Mutation
D000998:Antiviral Agents; D015684:Gene Products, pol; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D016056:Immunodominant Epitopes; C066027:P protein, Hepatitis B virus